alternative / integrative
Curcumin (C3 complex/Bioperine)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-03-27 — Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms: Phase II trial launched evaluating curcumin (C3 complex/Bioperine) supplementation in CCUS, low-risk MDS, and MPN patients with co-primary endpoints of reduced inflammatory response and improved symptom burden (trial-early, first prospective study in this disease context). (novelty: 3)
Open questions
Related
Contributing findings
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
27-mar-2026
novelty 3
per-area 3
introduces